Merck & Co. Says to Invest in Singapore Expansion and Research
By Alan Soughley -
2011-10-21T04:09:17Z
Merck & Co. will expand its presence in Singapore through new manufacturing, marketing and research investments, according to a joint announcement from the pharmaceutical company and the Singapore Economic Development Board.
Merck will spend $250 million over the next 10 years on improvements to its manufacturing site in Tuas, Singapore. It will also spend S$700 million on local research activities, it said.
To contact the editor responsible for this story: Alan Soughley at asoughley@bloomberg.net
Rate this Page
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.